Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLargo, Inc. (BLGO) had Revenue of $0.62M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$0.62M
Net Income	$-2.95M
Cost of Goods Sold	$0.49M
Gross Profit	$0.12M
Operating Expenses	$4.63M
Operating Income	$-4.01M
Non-Operating Income/Expense	$-0.13M
Pre-Tax Income	$-4.14M
Normalized Pre-Tax Income	$-4.14M
Income after Taxes	$-4.14M
Income from Continuous Operations	$-4.14M
Consolidated Net Income/Loss	$-4.14M
Normalized Income after Taxes	$-4.14M
EBIT	$-4.01M
EBITDA	$-4.09M
Weighted-Average Shares Outstanding (Basic)	306.95M
Weighted-Average Shares Outstanding (Diluted)	306.95M
Earnings per Share (EPS) (Basic)	$-0.01
Earnings per Share (EPS) (Diluted)	$-0.01
Balance Sheet Financials
Current Assets	$5.11M
Property, Plant, and Equipment	$1.64M
Long-Term Assets	$3.20M
Total Assets	$8.31M
Current Liabilities	$5.06M
Long-Term Debt	$0.86M
Long-Term Liabilities	$1.72M
Total Liabilities	$6.79M
Common Equity	$1.53M
Tangible Shareholders Equity	$1.53M
Shareholders Equity	$1.53M
Common Shares Outstanding	317.38M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.30M
Cash Flow from Investing Activities	$0.43M
Cash Flow from Financial Activities	$8.22M
Beginning Cash	$3.55M
End Cash	$3.88M
Increase/Decrease in Cash	$0.34M
Stock-Based Compensation	$3.61M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.01
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	1.60
Gross Margin	20.29%
Operating Margin	-651.14%
EBIT Margin	-651.14%
EBITDA Margin	--
Pre-Tax Profit Margin	-672.40%
Profit Margin	-479.55%
Free Cash Flow	$-8.34M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	1.58
Receiveable Turnover	1.00
Days Sales in Receivables	89.85
Return on Equity	-271.43%
Return on Tangible Equity	-271.43%
Return on Assets	-49.84%
Return on Investments	-173.74%
Book Value Per Share	$0.00
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.03

Data from Zacks Investment Research, Inc.